✦ LIBER ✦

Thalidomide in the management of multiple myeloma

✍ Scribed by Bart Barlogie; Maurizio Zangari; Trey Spencer; Athanasios Fassas; Elias Anaissie; Ashraf Badros; Jeana Cromer; Guido Tricot

Book ID: 117211220
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 920 KB
Volume: 38
Category: Article
ISSN: 1532-8686
DOI: 10.1016/s0037-1963(01)90017-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thalidomide in the management of multipl

Thalidomide in the management of multiple myeloma

✍ Bart Barlogie; Guido Tricot; Elias Anaissie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 621 KB

Consensus guidelines for the optimal man

Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma

✍ A. Palumbo; F. Davies; M. Kropff; J. Bladé; M. Delforge; F. Leal da Costa; R. Ga 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB

Thalidomide in multiple myeloma

✍ P Richardson; T Hideshima; K Anderson 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Thalidomide in multiple myeloma

📂 Article 📅 2005 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 96 KB

Thalidomide treatment in multiple myelom

Thalidomide treatment in multiple myeloma

✍ Kathrin Strasser; Heinz Ludwig 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Thalidomide was first evaluated in patients with refractory multiple myeloma in the mid-90s. Based on the promising results achieved in these patients, the drug was subsequently used in earlier stages of the disease. Meanwhile, numerous phase II studies have been published using different doses and

Thalidomide in the treatment of multiple

Thalidomide in the treatment of multiple myeloma

✍ Efstathios Kastritis; Meletios A. Dimopoulos 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 228 KB